XML 55 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
The Company (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 22, 2015
USD ($)
Jun. 30, 2015
USD ($)
Dec. 31, 2016
USD ($)
Systems
Channel
shares
Dec. 31, 2015
USD ($)
shares
Liquidity [Abstract]        
Accumulated deficit     $ (210,575) $ (207,240)
Reverse stock-split ratio     0.10  
Revenue Recognition [Abstract]        
Number of distribution channels | Channel     2  
Accounts Receivable, Net [Abstract]        
Allowance for doubtful accounts     $ 135 45
Inventories [Abstract]        
Reserves on inventory     257  
Inventory write-offs     $ 0 4,818
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     5 years  
Write-down, property and equipment   $ 920 $ 0 920
Finite-Lived Intangible Assets [Line Items]        
Impairment of intangible assets     0  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair value of debt     20,082 15,958
Product Warranty Accrual [Roll Forward]        
Accrual at beginning of year     226 48
Acquired in asset purchase     0 265
Additions charged to warranty expense     196 98
Expiring warranties/claimed satisfied     (307) (185)
Total     115 226
Less: current portion     (102) (168)
Accrued warranty, non-current portion     13 58
Earnings Per Share [Abstract]        
Net loss     (3,335) (27,909)
Gain on the change in fair value of the warrant liability     (5,396) $ (1,814)
Diluted loss     $ (8,731)  
Weighted average number of common and common equivalent shares outstanding [Abstract]        
Basic number of common shares outstanding (in shares) | shares     10,595,068 8,536,699
Dilutive effect of warrants (in shares) | shares     983,505  
Diluted number of common and common stock equivalent shares outstanding (in shares) | shares     11,578,573 8,536,699
Advertising Costs [Abstract]        
Advertising expense     $ 4,389 $ 2,500
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common stock equivalents (in shares) | shares     64,981,515 68,384,707
Minimum [Member]        
Product Warranty Liability [Line Items]        
Standard warranty period     1 year  
Offered warranty period     3 years  
Maximum [Member]        
Product Warranty Liability [Line Items]        
Standard warranty period     2 years  
Offered warranty period     4 years  
Computer Hardware and Software [Member] | Minimum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     3 years  
Computer Hardware and Software [Member] | Maximum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     7 years  
Furniture and Fixtures [Member] | Minimum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     3 years  
Furniture and Fixtures [Member] | Maximum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     7 years  
Machinery and Equipment [Member] | Minimum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     3 years  
Machinery and Equipment [Member] | Maximum [Member]        
Property, Plant and Equipment [Line Items]        
Property, plant and equipment, useful life     7 years  
Fair Value, Measurements, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant liability (Note 12)     $ 105 $ 7,042
Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant liability (Note 12)     0 0
Fair Value, Measurements, Recurring [Member] | Significant other Observable Inputs (Level 2) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant liability (Note 12)     0 0
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant liability (Note 12)     $ 105 $ 7,042
Patents and Licensed Technologies [Member] | Minimum [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     8 years  
Patents and Licensed Technologies [Member] | Maximum [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     12 years  
Core Technology [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     10 years  
Product Technology [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     5 years  
Other Intangible Assets [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     10 years  
XTRAC and VTRAC [Member]        
Business Acquisition [Line Items]        
Acquisition price $ 42,528      
XTRAC and VTRAC [Member] | Core Technology [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     10 years  
XTRAC and VTRAC [Member] | Product Technology [Member]        
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life     5 years  
XTRAC [Member]        
Business Acquisition [Line Items]        
Number of systems placed in dermatologists offices | Systems     775  
Common Stock Equivalents of Convertible Debentures [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common stock equivalents (in shares) | shares     46,105,715 46,435,127
Common Stock Purchase Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common stock equivalents (in shares) | shares     12,033,098 16,729,362
Common Stock Equivalents of Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common stock equivalents (in shares) | shares     2,339,180 2,535,866
Common Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common stock equivalents (in shares) | shares     4,503,522 2,684,352